Drugs News and Research

RSS

Drug company donates bird flu vaccine to World Health Organization

A donation by Swiss drug maker Roche, of enough of its Tamiflu antiviral drug to treat 3 million people against birdflu, could slow the spread of the outbreak among humans, especially in countries too poor to afford their own stockpile.

24 Aug 2005

Prince Charles champions alternative healthcare

According to media in the UK, Prince Charles has commissioned a report into how the government could save money by using alternative medicine in the public healthcare system.

24 Aug 2005

New drug that selectively blocks immune responses protects kidneys after transplant

In an international clinical trial, a new drug that selectively blocks immune responses has proved as effective in preventing acute kidney transplant rejection as cyclosporine, the standard anti-rejection treatment.

24 Aug 2005

Lorus identifies novel class of lead drug candidates from small molecule anticancer program

Lorus Therapeutics has announced the continued success in the development of its small molecule anticancer program with the selection of a sub-class of lead molecules from the Company's small molecule program.

24 Aug 2005

Taking aspirin longterm could reduce colorectal cancer risk

According to new report from the Nurses' Health Study (NHS), regular, long-term aspirin use can significantly reduce the risk of colorectal cancer.

24 Aug 2005

First human gene mutation that causes extreme farsightedness

Working with an Amish-Mennonite family tree, Johns Hopkins researchers at the Wilmer Eye Institute have discovered what appears to be the first human gene mutation that causes extreme farsightedness.

24 Aug 2005

First direct evidence that endorphins play a role in the phenomenon known as the placebo effect

Just thinking that a medicine will relieve pain is enough to prompt the brain to release its own natural painkillers, and soothe painful sensations, a new University of Michigan study finds.

23 Aug 2005

European Rare Diseases Therapeutic Initiative could provide an important new mechanism for developing new drugs

Because of the very high costs in developing drugs for rare genetic diseases, and the low return on investment, the pharmaceutical industry has rarely developed specific treatments for many of these diseases.

23 Aug 2005

Aspirin use can significantly reduce the risk of colorectal cancer

A new report from the Nurse's Health Study finds that regular, long-term aspirin use can significantly reduce the risk of colorectal cancer, as suggested by several earlier studies.

23 Aug 2005

Benefits of MAO-B inhibitors are small but may be worthwhile in some patients with early Parkinson's disease

A class of drugs known as MAO-B inhibitors may be effective in improving motor symptoms in people with early Parkinson's disease and may delay the need for treatment with other drugs, according to a new systematic review of current evidence.

23 Aug 2005

Study examines the incidence and risk factors associated with Hepatitis C infection in rural Egypt

The prevalence of antibodies to Hepatitis C Virus (HCV) in Egypt is among the highest in the world. From the 1950s until 1982 hundreds of thousands were infected during mass campaigns to control schistosomiasis (a parasitic disease) using mass therapy with intravenous antimony compounds, but little is known about current risk factors and rates of transmission.

23 Aug 2005

Patients with primary biliary cirrhosis who are treated with methotrexate have an increased risk of death

In five randomized controlled trials involving 457 people, the authors report that for patients treated with methotrexate, as a single therapy or in combination with other drug treatment, pooled data showed a tendency toward an increased risk of death or liver transplantation. The brand names for methotrexate are Rheumatrex and Trexall.

23 Aug 2005

Appropriate tests need to be done earlier for ovarian cancer

A new study to be published in the journal CANCER in October has found that many women diagnosed with ovarian cancer actually complained of symptoms of the disease at least four months before they were diagnosed.

23 Aug 2005

Drug company disputes claim of new study on antidepressant Paxil

Drug company GlaxoSmithKline (GSK) is disputing claims that its antidepressant Paxil was linked to an increased suicide risk in adults.

23 Aug 2005

Epidemiological study links heart protection with non-aspirin, non-steroidal drugs

It is well known that aspirin, a non-selective, non-steroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX), reduces the risk of heart attack and stroke.

22 Aug 2005

Study shows potential treatment for brain cancer

A compound that kills cancer can sneak past the blood brain barrier, which protects the brain from foreign substances, to do its work in fighting a particularly invasive brain cancer, according to a new Saint Louis University animal study published in the Proceedings of the National Academy of Sciences Online Early Edition the week of Aug. 22.

22 Aug 2005

Chemists synthesize new class of carbenes - potential for pharmaceutical industry

Chemists at the University of California, Riverside have synthesized a new class of carbenes - molecules that have unusual carbon atoms - that is expected to have wide applications in the pharmaceutical industry, ultimately resulting in a reduction in the price of drugs.

22 Aug 2005

New post-graduate qualification will help counter a world-wide shortage of forensic medicine experts

A new degree designed to equip doctors and scientists with the expertise needed to investigate deaths resulting from acts of genocide, terrorism, natural disasters such as Tsunami, transport accidents and drug abuse will be launched this week at an international Forensic Science conference in Hong Kong.

22 Aug 2005

Stockings which provide an alternative to physiotherapy

A team of researchers at Imperial College London have developed inflatable stockings to give relief to elderly people with mobility problems.

22 Aug 2005

Enzyme in the blood that could be a potential marker for heart failure

A team of scientists led by Walter Koch, Ph.D., director of the Center for Translational Medicine in the Department of Medicine in Jefferson Medical College of Thomas Jefferson University in Philadelphia, previously showed that an enzyme called GRK2 or beta-adrenergic kinase (ßARK1) is critically important in heart function.

22 Aug 2005

Drugs News and Research

Drug company donates bird flu vaccine to World Health Organization

Prince Charles champions alternative healthcare

New drug that selectively blocks immune responses protects kidneys after transplant

Lorus identifies novel class of lead drug candidates from small molecule anticancer program

Taking aspirin longterm could reduce colorectal cancer risk

First human gene mutation that causes extreme farsightedness

First direct evidence that endorphins play a role in the phenomenon known as the placebo effect

European Rare Diseases Therapeutic Initiative could provide an important new mechanism for developing new drugs

Aspirin use can significantly reduce the risk of colorectal cancer

Benefits of MAO-B inhibitors are small but may be worthwhile in some patients with early Parkinson's disease

Study examines the incidence and risk factors associated with Hepatitis C infection in rural Egypt

Patients with primary biliary cirrhosis who are treated with methotrexate have an increased risk of death

Appropriate tests need to be done earlier for ovarian cancer

Drug company disputes claim of new study on antidepressant Paxil

Epidemiological study links heart protection with non-aspirin, non-steroidal drugs

Study shows potential treatment for brain cancer

Chemists synthesize new class of carbenes - potential for pharmaceutical industry

New post-graduate qualification will help counter a world-wide shortage of forensic medicine experts

Stockings which provide an alternative to physiotherapy

Enzyme in the blood that could be a potential marker for heart failure

Drug Discovery - Second Edition eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News